Repeatability of Static & Dynamic Composite Confocal Microscopy for Assessment of the Corneal Nerve Fiber Plexus in Early Diabetic Polyneuropathy
NCT ID: NCT05326958
Last Updated: 2022-05-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
96 participants
INTERVENTIONAL
2016-07-31
2018-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Part 1 assessed Repeatability in healthy, non-diabetic population (Group "control").
Part 2 collected data to evaluate the diagnostic and prognostic value of using Heidelberg Engineering Retina Tomograph (HRT) 3 with the Rostock Cornea Module EyeGuidance functional module (HRT RCM-E) in subjects with early to moderate DPN (Groups"none" and "mild", respectively).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Corneal Confocal Microscopy in Patients With Type 1 Diabetes
NCT03045250
Corneal Confocal Microscopy to Detect Diabetic Neuropathy in Children
NCT02321904
Evaluation of Corneal Confocal Microscopy for the Identification and Prediction of Neuropathy in Type 1 Diabetes
NCT02423434
A Comparison Between Pupillometry, Heart Rate Variability and Metaiodobenzylguanidine Scintigraphy for the Diagnosis of Early Diabetic Autonomic Neuropathy in Type 1 Diabetes
NCT01822431
Characterization and Prediction of Early Onset Diabetic Peripheral Neuropathy
NCT05546138
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The part 2 (research part) evaluated changes in corneal nerve plexus parameters in diabetes patients without or with early to moderate Diabetic Peripheral Neuropathy (DPN) and correlated the observed changes with progression of early DPN.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Normal Eyes of Subjects without DM
Study Part 1 conducted at only site 1 . Single measurement made on 3 separate visits at site 1 (total 3 images acquired) with HRT RCM and HRT RCM-E functional module (investigational).
HRT RCM
Imaging with HRT RCM done only at site 1 (on normal eyes of subjects without DM).
HRT RCM-E
imaging done on eyes of all enrolled subjects at site 1 and site 2.
Eyes of DM Type 2 subjects without coexisting DPN
Study part 2 conducted at site 2.
1 image acquired with HRT RCM-E functional module (investigational).
HRT RCM-E
imaging done on eyes of all enrolled subjects at site 1 and site 2.
Eyes of DM Type 2 subjects with coexisting early to moderate DPN
Study part 2 conducted at site 2.
1 image acquired with HRT RCM-E functional module (investigational).
HRT RCM-E
imaging done on eyes of all enrolled subjects at site 1 and site 2.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
HRT RCM
Imaging with HRT RCM done only at site 1 (on normal eyes of subjects without DM).
HRT RCM-E
imaging done on eyes of all enrolled subjects at site 1 and site 2.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able and willing to undergo the test procedures, give consent, and to follow instructions.
* Signed informed consent.
* ≥18 years.
* Part 1, Site 1
* Normal eyes of patients without Diabetes Mellitus
* Fasting blood glucose \< 100 mg/dl
* HbA1c ≤ 6.5%
* Part 2, Site 2
* Diabetes Mellitus Type 2 without coexisting DPN (NSS score ≤2 and / or NDS score ≤2)
* Diabetes Mellitus Type 2 with coexisting early to moderate DPN. (NSS score 3-4 and / or NDS score 3-5)
* 6.5% \< HbA1c ≤ 9.5%
Exclusion Criteria
* Subjects unable to read or write
* Contact lens wearers (soft and rigid)
* Patients with symptomatic dry eye
* Patients with conjunctivitis at the time of inclusion
* Patients with history of corneal surgery
* Patients with diabetic retinopathy
* Patients with history of neuronal diseases that according to the expertise of the investigator might have an influence on corneal nerve fiber plexus
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Heidelberg Engineering GmbH
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Prof.Dr.Rudolf Guthoff
Role: PRINCIPAL_INVESTIGATOR
Universitätsmedizin Rostock
Univ.Prof.Dr.med.Dr.h.c.Diethelm Tschöpe
Role: PRINCIPAL_INVESTIGATOR
Herz- und Diabeteszentrum NRW, UKRUB, Universitätsklinik der Ruhr Universität Bochum
Priv.-Dozent Dr. med.Hans-Joachim Hettlich
Role:
Augen-Praxisklinik Minden
References
Explore related publications, articles, or registry entries linked to this study.
Matuszewska-Iwanicka A, Stratmann B, Stachs O, Allgeier S, Bartschat A, Winter K, Guthoff R, Tschoepe D, Hettlich HJ. Mosaic vs. Single Image Analysis with Confocal Microscopy of the Corneal Nerve Plexus for Diagnosis of Early Diabetic Peripheral Neuropathy. Ophthalmol Ther. 2022 Dec;11(6):2211-2223. doi: 10.1007/s40123-022-00574-z. Epub 2022 Oct 3.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
E-2015-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.